Literature DB >> 12425865

Overactive bladder in the male patient: bladder, outlet, or both?

Khaled F Abdel-Aziz1, Gary E Lemack.   

Abstract

Generations of urologists have presumed that the cause of lower urinary tract symptoms (LUTS) in men is infravesical (prostatic) obstruction. When symptoms such as urinary urgency and frequency can't easily be explained directly by obstruction, secondary effects of obstruction on the bladder are identified as causative factors. Although to some extent this explanation may still be accurate, emerging concepts in the pathophysiology of LUTS in men may be at odds with these traditional explanations. The idea that primary bladder pathology may explain the symptom complex in at least one subset of men with LUTS has both experimental and clinical support. This review discusses the physiologic and clinical observations used to explain the mechanisms underlying LUTS. Specifically, this review focuses on two data sets: one supporting infravesical obstruction as the causative factor for LUTS, and another positing that a primary bladder abnormality is responsible.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12425865     DOI: 10.1007/s11934-002-0095-3

Source DB:  PubMed          Journal:  Curr Urol Rep        ISSN: 1527-2737            Impact factor:   2.862


  47 in total

Review 1.  The role of alpha1-adrenergic receptor subtypes in lower urinary tract symptoms.

Authors:  D A Schwinn
Journal:  BJU Int       Date:  2001-09       Impact factor: 5.588

2.  Different voiding dynamics in stable and unstable bladders with and without outlet obstruction.

Authors:  A Cucchi
Journal:  Neurourol Urodyn       Date:  1998       Impact factor: 2.696

Review 3.  alpha1-adrenoceptors and bladder function.

Authors:  K Andersson
Journal:  Eur Urol       Date:  1999       Impact factor: 20.096

4.  Bladder outflow obstruction--a cause of denervation supersensitivity.

Authors:  M J Speakman; A F Brading; C J Gilpin; J S Dixon; S A Gilpin; J A Gosling
Journal:  J Urol       Date:  1987-12       Impact factor: 7.450

5.  Effect of distension on blood flow in dog's urinary bladder.

Authors:  A Finkbeiner; J Lapides
Journal:  Invest Urol       Date:  1974-11

6.  The results of prostatectomy: a symptomatic and urodynamic analysis of 152 patients.

Authors:  P H Abrams; D J Farrar; R T Turner-Warwick; C G Whiteside; R C Feneley
Journal:  J Urol       Date:  1979-05       Impact factor: 7.450

7.  Can persisting detrusor hyperreflexia be predicted after transurethral prostatectomy for benign prostatic hypertrophy?

Authors:  S Kageyama; T Watanabe; Y Kurita; T Ushiyama; K Suzuki; K Fujita
Journal:  Neurourol Urodyn       Date:  2000       Impact factor: 2.696

8.  The effect of experimental urethral obstruction and its reversal on changes in passive electrical properties of detrusor muscle.

Authors:  N Seki; O M Karim; J L Mostwin
Journal:  J Urol       Date:  1992-12       Impact factor: 7.450

9.  Transurethral incision of the prostate: an objective and subjective evaluation of long-term efficacy.

Authors:  L T Sirls; K Ganabathi; P E Zimmern; D A Roskamp; G Wolde-Tsadik; G E Leach
Journal:  J Urol       Date:  1993-11       Impact factor: 7.450

10.  Effect of terazosin on urine storage and voiding in the aging male with prostatism.

Authors:  D M Gleason; M R Bottaccini
Journal:  Neurourol Urodyn       Date:  1994       Impact factor: 2.696

View more
  13 in total

1.  Medical therapy for benign prostatic hyperplasia: new terminology, new concepts, better choices.

Authors:  Steven A Kaplan
Journal:  Rev Urol       Date:  2006

Review 2.  The future of bladder research: molecular profiling, new drug targets, gene therapy, and tissue engineering.

Authors:  George Christ; Karl-Erik Andersson; Anthony Atala
Journal:  Curr Urol Rep       Date:  2007-03       Impact factor: 3.092

Review 3.  Combination pharmacological therapies for the management of benign prostatic hyperplasia.

Authors:  Seth A Cohen; J Kellogg Parsons
Journal:  Drugs Aging       Date:  2012-04-01       Impact factor: 3.923

4.  The attitudes of Urologists and Gynecologists about overactive bladder and treatment of it in Turkey: A questionnaire survey.

Authors:  Burhan Coşkun; Ömer Bayrak; Murat Dinçer; Kadir Önem; Cenk Gürbüz; Rahmi Onur
Journal:  Turk J Urol       Date:  2017-01-27

Review 5.  Links between lower urinary tract symptoms, intermittent hypoxia and diabetes: Causes or cures?

Authors:  Lisa L Abler; Chad M Vezina
Journal:  Respir Physiol Neurobiol       Date:  2017-09-18       Impact factor: 1.931

6.  Overactive bladder and outlet obstruction in men.

Authors:  Doreen E Chung; Jaspreet S Sandhu
Journal:  Curr Urol Rep       Date:  2011-02       Impact factor: 3.092

7.  Changes in Awake Cystometry and Expression of Bladder β-adrenoceptors after Partial Bladder Outlet Obstruction in Male Rats.

Authors:  Min Gu Park; Hong Seok Park; Jeong Gu Lee; Hyung Jee Kim
Journal:  Int Neurourol J       Date:  2010-10-31       Impact factor: 2.835

Review 8.  New intraprostatic injectables and prostatic urethral lift for male LUTS.

Authors:  Giuseppe Magistro; Christian G Stief; Christian Gratzke
Journal:  Nat Rev Urol       Date:  2015-07-21       Impact factor: 14.432

9.  The urologist's view of male overactive bladder: discrepancy between reality and belief in practical setting.

Authors:  Seung Hwan Lee; Dae Kyung Kim; Joon Chul Kim; Kyu-Sung Lee; Jeong Gu Lee; Choal Hee Park; Sung Joon Hong; Choung-Soo Kim; Jong Kwan Park; Byung Ha Chung
Journal:  Yonsei Med J       Date:  2010-05       Impact factor: 2.759

10.  Three-dimensional ultrasound bladder characteristics and their association with prostate size and lower urinary tract dysfunction among men in the community.

Authors:  Andrew D Rule; Jennifer L St Sauver; Debra J Jacobson; Michaela E McGree; Cynthia J Girman; Michael M Lieber; Steven J Jacobsen
Journal:  Urology       Date:  2009-08-03       Impact factor: 2.649

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.